Alligator Bioscience

Alligator Bioscience Intangible Assets

The Intangible Assets of Alligator Bioscience (ATORX.ST) as of Oct 17, 2026 is 27.87 M SEK. In the previous year, Intangible Assets was 17.96 M SEK — a change of 55.12% (higher).

Intangible Assets

27.87 MSEK

YoY

55.12%

Last updated:

Intangible Assets of Alligator Bioscience is 2024 27.87 M SEK. Intangible Assets of Alligator Bioscience was 2023 17.96 M SEK. It decreases by 55.12% higher compared to the previous year.

The Alligator Bioscience Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
19.40 M SEK
Jan 1, 2018
19.12 M SEK
Jan 1, 2019
18.65 M SEK
Jan 1, 2020
18.35 M SEK
Jan 1, 2021
18.17 M SEK
Jan 1, 2022
18.02 M SEK
Jan 1, 2023
17.96 M SEK
Jan 1, 2024
27.87 M SEK
The Alligator Bioscience Intangible Assets history
YEARIntangible AssetsYoY
27.87 MSEK+55.12%
17.96 MSEK-0.31%
18.02 MSEK-0.81%
18.17 MSEK-1.01%
18.35 MSEK-1.57%
18.65 MSEK-2.46%
19.12 MSEK-1.48%
19.40 MSEK-4.21%
20.26 MSEK-53.33%
43.40 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Alligator Bioscience Stock analysis

What does Alligator Bioscience do? Alligator Bioscience AB, headquartered in Lund, Sweden, is a biotechnology company specializing in the development of antibody-based immunotherapies for cancer treatment. The company utilizes its ALLIGATOR-GOLD antibody library and FIND optimization technology to create tumor-directed therapies, including mono- and bispecific antibodies. With a pipeline featuring three preclinical-stage projects—ADC-1013, ATOR-1015, and ATOR-1016—the firm focuses on innovative cancer immunotherapies. Listed on 23 November 2016, it employs 43 full-time staff. Alligator Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alligator Bioscience stock

Intangible Assets of Alligator Bioscience is 27.87 M SEK in 2024.

Intangible Assets of Alligator Bioscience changed from 17.96 M SEK to 27.87 M SEK, representing a 55.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Alligator Bioscience since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Alligator Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Alligator Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Alligator Bioscience